KindlyMD, Inc. (NASDAQ:NAKA – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $4.08, but opened at $3.76. KindlyMD shares last traded at $4.74, with a volume of 2,139,033 shares.
Analyst Upgrades and Downgrades
Separately, Maxim Group assumed coverage on shares of KindlyMD in a research note on Wednesday, September 3rd. They issued a “buy” rating and a $8.00 target price for the company. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $8.00.
View Our Latest Research Report on NAKA
KindlyMD Stock Up 24.0%
KindlyMD (NASDAQ:NAKA – Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The company had revenue of $0.41 million for the quarter.
KindlyMD Company Profile
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Read More
- Five stocks we like better than KindlyMD
- What is diluted earnings per share (Diluted EPS)?
- Insiders Sell These High-Quality Stocks: Why Investors Shouldn’t
- What is the Shanghai Stock Exchange Composite Index?
- 5 Clean Energy Stocks Poised for the Next Green Rally
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- What August Labor Data Means for the S&P 500 in September
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
